Public Company News

Goodbaby International Holdings Limited Announces First Quarter Revenue Performance

Group Revenue Records Positive Growth  Despite Extremely Volatile Macro Environment  CYBEX Maintains Strong Momentum and Achieves Double-Digit Revenue Growth HONG KONG, May 8, 2025 /PRNewswire/ -- Goodbaby International Holdings Limited ("Goodbaby International" or the "Company"; HKEX stock code: ...

2025-05-08 17:09 4276

Baidu to Hold Annual General Meeting on June 27, 2025

BEIJING, May 8, 2025 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today announced that it will hold its annual general meeting of shareholders (the "AGM") at Baidu Cam...

2025-05-08 17:00 2318

Acer Announces Q1'25 Operating Income at NT$1.04 Billion, Up 33.0% Year-on-Year

Margins for gross profit and operating income grow year-on-year TAIPEI, May 8, 2025 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its financial results for the first quarter of 2025. Consolidated revenues reached NT$61.34 billion, up 4.3% year-on-year (YoY); gross profits reached NT$6.48 billi...

2025-05-08 16:26 3932

Qifu Technology's Paper Accepted by IJCAI 2025, Using MLLM to Pave New Path in Fintech

SHANGHAI, May 7, 2025 /PRNewswire/ -- China's leading fintech company Qifu Technology ( NASDAQ: QFIN; HKEX: 3660) and Beijing Jiaotong University have jointly achieved a significant milestone as their paper,Leveraging MLLM Embeddings and Attribute Smoothing for Compositional Zero-Shot Learning, h...

2025-05-08 13:52 4028

Penetrium™ Breaks Oncology Barriers: The Solution to Cold Tumors and Metastatic Cancer Unveiled at AACR 2025

* Penetrium™ Achieves Historic Breakthrough * Overcoming Cold Tumor Failure and the Challenge of Metastatic Cancer in Immunotherapy and Antibody Therapy * Presented at AACR 2025, Chicago CHICAGO, May 7, 2025 /PRNewswire/ -- Hyundai Bioscience presented the results of its Penetrium™ combinati...

2025-05-08 09:03 2466

HANYUL Exclusively Launches at Sephora, Bringing Authentic Korean Beauty to U.S. Consumers

NEW YORK, May 7, 2025 /PRNewswire/ -- HANYUL, a renowned leader in Korean beauty, is set to launch at Sephora onMay 16, 2025. This exciting new partnership will bring HANYUL's signature skincare to U.S. consumers both online and in Sephora stores nationwide. Known for combining the finest tradit...

2025-05-07 23:00 2625

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

The five-year framework agreement covers phased rollout of Lunit's AI suite—including chest X-ray, mammography, tomosynthesis, and fracture detection—across 79 Starvision sites SEOUL, South Korea, May 7, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics ...

2025-05-07 21:00 2530

Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment

ONTARIO, Calif., May 7, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing agreement (the "Financing") with GHS Investments L...

2025-05-07 20:30 4124

TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids

* Primary Endpoint Met: Statistically significant reduction in heavy menstrual bleeding achieved in all dosage of Merigolix groups compared to placebo * Broader Therapeutic Potential: Positive Phase 2 results in both uterine fibroids and endometriosis could place Merigolix as a strong best-in...

2025-05-07 20:00 2241

Zepp Health Corporation to Report First Quarter 2025 Financial Results on May 19, 2025

Earnings Call Scheduled for 9:00 p.m. ET on May 19, 2025 MILPITAS, Calif., May 7, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its first quarter 2025 unaud...

2025-05-07 20:00 4267

Baozun to Announce First Quarter 2025 Unaudited Financial Results on May 21, 2025

SHANGHAI, May 7, 2025 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced that it will release its unaudited financial results for the first quarter e...

2025-05-07 18:00 3814

CreateAI Releases White Paper on how AI Transforms Animation Production

BEIJING, May 6, 2025 /PRNewswire/ -- CreateAI Holdings Inc. (OTCMKTS: TSPH) ("CreateAI" or the "Company"), a global artificial intelligence technology company, today announced the release of its "White Paper on the Application and Development of Multimodal Generative Technology in Animation Produ...

2025-05-07 10:00 3969

CStone Presents Preclinical Results of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bispecific ADC), CS5005 (SSTR2 ADC) and CS5006 (ITGB4 ADC) at 2025 AACR

SUZHOU, China, May 6, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that poster presentations of preclinical data of CS2011 (EGFR/HER3 bispecific antibody), CS5007 (EGFR/HER3 bis...

2025-05-07 08:00 1976

Formosa Pharmaceuticals Announces Licensing Agreement with Apotex Inc., for Commercialization of Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain for Mexico

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals (" Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Apotex Inc. ("Apotex"), for exclusive rights inMexico for the commercialization of clobetasol propionate ophthalmic...

2025-05-07 06:30 1916

Golden Heaven Group Holdings Ltd. Announces 25 for 1 Share Consolidation

NANPING, China, May 6, 2025 /PRNewswire/ -- Golden Heaven Group Holdings Ltd. (" Golden Heaven" or the "Company") (Nasdaq: GDHG), an amusement park operator in China, today announced that the Company's board of directors approved on April 23, 2025 that the authorized, issued, and outstanding shares...

2025-05-07 04:30 3781

XChange TEC.INC Announces Plan to Implement ADS Ratio Change

SHANGHAI, May 6, 2025 /PRNewswire/ -- XChange TEC.INC (NASDAQ: XHG) (the "Company") today announced that it plans to change the ratio of the American depositary shares ("ADSs") representing its Class A ordinary shares from one (1) ADS representing one hundred and twenty (120) Class A ordinary sha...

2025-05-07 04:30 3462

Xiao-I Corporation Expands Strategic Partnership with AIA China Through RMB 3-4 Million AI Solutions Deal

SHANGHAI, May 6, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a leading AI enterprise, announced the expansion of its partnership with AIA China, a leading insurance provider, through a one-year contract valued at RMB 3–4 million. This collaboration underscores Xiao-I's position as a p...

2025-05-06 21:30 4505

Webull Announces Collaboration with Visa

With Webull and Visa Direct, users can move money to and from investment accounts in real-time[1] NEW YORK, May 6, 2025 /PRNewswire/ -- Webull (Nasdaq: BULL), an online investment platform, today announced its collaboration with VISA on the Webull US platform.Visa Direct...

2025-05-06 21:00 3956

Formosa Pharmaceuticals and Almac Discovery Announce Licensing Agreement for ALM-401, a First-in-Class Bispecific ADC targeting EGFR/ROR1 for the Treatment of Solid Tumors

TAIPEI, May 6, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Almac Discovery, aNorthern Ireland-based research driven drug discovery company, for exclusive rights to the commercializ...

2025-05-06 21:00 2119

SK bioscience Joins Korea's National Initiative to Develop Avian Influenza Vaccine Amid Rising Pandemic Threats

* Company aims to develop a bird flu vaccine with rapid mass production and variant responsiveness. * SK bioscience and KDCA join forces to build a national pandemic preparedness and response system for potential next-pandemic avian influenza. * "We will promote global public health and grow...

2025-05-06 20:00 2494
1 ... 80818283848586 ... 777